Specifically, flickering light stimulation (FLS) at 40 Hz significantly reduces AD pathologies in mice, leading to reduced amyloid and tau protein levels, prevention of cerebral atrophy, and improved behavioral testing performance [30]. The gene discussed is MAPT; the disease is Alzheimer disease.